Source: Atherosclerosis. Unidades: FM, FCF
Subjects: LIPOPROTEÍNAS (TERAPIA), DOENÇAS CARDIOVASCULARES
ABNT
MANGILI, Otavio Celeste et al. Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects. Atherosclerosis, v. 233, n. 1, p. 319-325, 2014Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2013.12.008. Acesso em: 19 nov. 2024.APA
Mangili, O. C., Gagliardi, A. C. M., Mangili, L. C., Mesquita, C. H., Cesar, L. A. M., Tanaka, A., et al. (2014). Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects. Atherosclerosis, 233( 1), 319-325. doi:10.1016/j.atherosclerosis.2013.12.008NLM
Mangili OC, Gagliardi ACM, Mangili LC, Mesquita CH, Cesar LAM, Tanaka A, Schaefer EJ, Maranhão RC, Santos RD. Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects [Internet]. Atherosclerosis. 2014 ; 233( 1): 319-325.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2013.12.008Vancouver
Mangili OC, Gagliardi ACM, Mangili LC, Mesquita CH, Cesar LAM, Tanaka A, Schaefer EJ, Maranhão RC, Santos RD. Favorable effects of ezetimibe alone or in association with simvastatin on the removal from plasma of chylomicrons in coronary heart disease subjects [Internet]. Atherosclerosis. 2014 ; 233( 1): 319-325.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2013.12.008